Evidence map›Paper›PMID 38778076›Full record

ArticleScientific reports2024

Serum levels of stem cell factor for predicting embryo quality.

Joanna Liss, Martyna Kuczyńska, Michał Kunicki, Krystian Zieliński, Damian Drzyzga

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joanna LissResearch and Development Center, INVICTA, Polna 64, 81-740, Sopot, Poland.ORCID 0000-0002-9199-5212
Martyna KuczyńskaDepartment of Medical Biology and Genetics, University of Gdańsk, Gdańsk, Poland.
Michał KunickiResearch and Development Center, INVICTA, Polna 64, 81-740, Sopot, Poland. michal.kunicki@wum.edu.pl.ORCID 0000-0001-9672-3382
Krystian ZielińskiResearch and Development Center, INVICTA, Polna 64, 81-740, Sopot, Poland.ORCID 0000-0003-1610-5440
Damian DrzyzgaResearch and Development Center, INVICTA, Polna 64, 81-740, Sopot, Poland.ORCID 0000-0002-6466-2412

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated whether serum stem cell factor (s-SCF) levels just prior to ovulation induction could indicate the ability to develop a top-quality (TQ) blastocyst by day 5. We investigated patients with normal ovarian reserve (NOR), polycystic ovary syndrome (PCOS), diminished ovarian reserve (DOR), or mild endometriosis. Our pilot research suggests a correlation between s-SCF levels and the ability to form TQ blastocysts in patients with mild endometriosis. This significant statistical difference (p < 0.05) was noted between mild endometriosis patients for whom a TQ blastocyst was obtained and those for whom it was not possible, as measured on the 8th day of stimulation and the day of oocyte retrieval. The mean SCF levels in the serum of these women on the 8th day were at 28.07 (± 2.67) pg/ml for the TQ subgroup and 53.32 (± 16.02) pg/ml for the non-TQ subgroup (p < 0.05). On oocyte retrieval day it was 33.47 (± 3.93) pg/ml and 52.23 (± 9.72) pg/ml (p < 0.05), respectively.

Indexed as

BlastocystOvarian ReserveStem Cell FactorAdultEndometriosisFemaleFertilization in VitroHumansOocyte RetrievalOvulation InductionPilot ProjectsPolycystic Ovary SyndromeStem Cell FactorAssisted reproductive treatmentControlled ovarian hyperstimulationEmbryo qualityEndometriosisSCFStem cell factor

Identifiers

PMID38778076
PMCPMC11111753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.